RNU6-667P

Across TCGA pan-cancer cohorts, RNU6-667P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-667P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU6-667P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-667P expression acts as an unfavorable survival marker, although some lineages such as LUAD and STAD show a favorable association.

TGCT, COAD, and ESCA are the cancer types where RNU6-667P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	60	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	45	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
MESO	DFS	Tertile	IV	0.059	0.361	.002	36	view →
KIRC	OS	Quartile	II,III,IV	0.691	0.805	.010	22	view →
ACC	DFS	Tertile	All	0.124	0.644	.006	21	view →
LUAD	DFS	Tertile	All	0.913	0.305	.014	12	view →
STAD	DFS	Tertile	IV	0.520	0.250	.033	9	view →
BLCA	DFS	Tertile	All	1.000	0.336	.038	9	view →
UVM	DFS	Tertile	III,IV	0.079	0.635	.021	9	view →
SKCM	DFS	Tertile	IV	0.040	0.432	.038	9	view →
KIRP	OS	Tertile	All	0.470	0.728	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU6-667P–TGCT (OS)

Open the TGCT breakdown →